Granite Point Capital

Cerebral Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Aurora, Colorado, focused on developing innovative drug-device combination therapies for neurologic diseases, particularly refractory epilepsy. The company employs a unique implanted, refillable catheter and pump system to deliver a continuous intracerebroventricular (ICV) dose of valproic acid, an anti-epileptic drug formulated as CT-010. By utilizing reformulated off-patent drugs delivered directly to the brain's ventricles, Cerebral Therapeutics aims to bypass the blood-brain barrier, thereby enhancing treatment outcomes for patients suffering from chronic neurological conditions. Established in 2010, the company is committed to improving the quality of life for those with uncontrolled neurological disorders.

Receptor Life Sciences, Inc. is a Seattle-based company founded in 2015 that focuses on developing inhaled therapeutic products for various medical conditions, including chronic pain, neurologic diseases, and inflammatory disorders. The company specializes in drug-delivery technologies aimed at treating nervous system disorders and also offers oral cannabinoid products. Receptor Life Sciences is dedicated to commercializing therapies that address unmet medical needs in the healthcare market.

Antios Therapeutics, Inc. is a biopharmaceutical company based in Atlanta, Georgia, focused on developing innovative therapies for viral diseases. Founded in 2018 by Abel De La Rosa, Douglas Mayers, and Idean Marvasty, the company is dedicated to addressing the needs of patients infected with Hepatitis B and Hepatitis D viruses. Its lead product, ATI-2173, is an oral drug candidate aimed at providing a potentially curative treatment for Hepatitis B virus infections. With a leadership team that brings a wealth of experience, Antios Therapeutics is committed to advancing its therapeutic solutions in the field of viral diseases.

Founded in 2015, Teikametrics specializes in e-commerce optimization for online marketplaces. Its AI-driven platform offers pricing optimization, inventory management, and operational efficiency tools, empowering retailers of all sizes to enhance profitability.

Antios Therapeutics, Inc. is a biopharmaceutical company based in Atlanta, Georgia, focused on developing innovative therapies for viral diseases. Founded in 2018 by Abel De La Rosa, Douglas Mayers, and Idean Marvasty, the company is dedicated to addressing the needs of patients infected with Hepatitis B and Hepatitis D viruses. Its lead product, ATI-2173, is an oral drug candidate aimed at providing a potentially curative treatment for Hepatitis B virus infections. With a leadership team that brings a wealth of experience, Antios Therapeutics is committed to advancing its therapeutic solutions in the field of viral diseases.

Founded in 2015, Teikametrics specializes in e-commerce optimization for online marketplaces. Its AI-driven platform offers pricing optimization, inventory management, and operational efficiency tools, empowering retailers of all sizes to enhance profitability.

Cerebral Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Aurora, Colorado, focused on developing innovative drug-device combination therapies for neurologic diseases, particularly refractory epilepsy. The company employs a unique implanted, refillable catheter and pump system to deliver a continuous intracerebroventricular (ICV) dose of valproic acid, an anti-epileptic drug formulated as CT-010. By utilizing reformulated off-patent drugs delivered directly to the brain's ventricles, Cerebral Therapeutics aims to bypass the blood-brain barrier, thereby enhancing treatment outcomes for patients suffering from chronic neurological conditions. Established in 2010, the company is committed to improving the quality of life for those with uncontrolled neurological disorders.

Cerebral Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Aurora, Colorado, focused on developing innovative drug-device combination therapies for neurologic diseases, particularly refractory epilepsy. The company employs a unique implanted, refillable catheter and pump system to deliver a continuous intracerebroventricular (ICV) dose of valproic acid, an anti-epileptic drug formulated as CT-010. By utilizing reformulated off-patent drugs delivered directly to the brain's ventricles, Cerebral Therapeutics aims to bypass the blood-brain barrier, thereby enhancing treatment outcomes for patients suffering from chronic neurological conditions. Established in 2010, the company is committed to improving the quality of life for those with uncontrolled neurological disorders.

Founded in 2015, Teikametrics specializes in e-commerce optimization for online marketplaces. Its AI-driven platform offers pricing optimization, inventory management, and operational efficiency tools, empowering retailers of all sizes to enhance profitability.

Cerebral Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Aurora, Colorado, focused on developing innovative drug-device combination therapies for neurologic diseases, particularly refractory epilepsy. The company employs a unique implanted, refillable catheter and pump system to deliver a continuous intracerebroventricular (ICV) dose of valproic acid, an anti-epileptic drug formulated as CT-010. By utilizing reformulated off-patent drugs delivered directly to the brain's ventricles, Cerebral Therapeutics aims to bypass the blood-brain barrier, thereby enhancing treatment outcomes for patients suffering from chronic neurological conditions. Established in 2010, the company is committed to improving the quality of life for those with uncontrolled neurological disorders.

DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.

Engage Therapeutics, Inc. is a biopharmaceutical company based in Summit, New Jersey, focused on developing innovative therapies for individuals experiencing uncontrolled epileptic seizures. Its lead investigational product, Staccato alprazolam, is a small, handheld drug-device combination designed for the rapid cessation of active and acute seizures. Utilizing an FDA-approved delivery system, the Staccato device administers alprazolam, an established benzodiazepine, in a single inhalation. The product has shown promise in a Phase 2a proof of concept study, which indicated potential reductions in seizures within a photosensitivity model. Engage Therapeutics is advancing Staccato alprazolam through clinical development, employing a 505(b)(2) regulatory pathway to facilitate its market entry.

Cyber adAPT protects critical business assets by detecting sophisticated adversaries hiding within enterprise networks. Its real-time network-based threat detection platform analyzes traffic to identify malicious attacks that have breached corporate defenses, enabling clients to inspect, detect, and respond effectively.

Healthguru.com is the destination site for health video on the web with 99 million views per month (comScore Video Metrix, August). Our unique approach to health education was developed specifically for the video audience and is differentiated in three key ways: - Category Focus: Healthguru.com focuses on the health topics that matter most to today's audience, including: diet and fitness, mental & emotional health, sexual health, pregnancy, baby health, drugs & alcohol, as well as information on more than 125 different health conditions. - Medium: The modern health consumer seeks out an immersive, rich media experience on the web, and video has proven to be a more engaging medium. Healthguru.com has the largest health video library online, and interactive applications to offer our audience the experience it expects. - Editorial Approach: World-class information providers know that creating truly engaging content is the way to ensure that information becomes learning. That's why Healthguru.com is dedicated to making our content as interesting and, when relevant, entertaining, as it is useful. All Healthguru.com content is created or selected by our editorial team and is rigorously reviewed for medical accuracy, objectivity and balance. While we do accept advertising on our site and may distribute content via third party sites, Healthguru.com does not endorse products, services or companies.